Icatibant Injection, Solution
Product Images NDC 63323-574

24 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 63323-574). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Chemical Structure (Ica00 0005 01)

Figure 1  Chemical Structure (Ica00 0005 01)
Chemical structure of Icatibant, the active ingredient in the drug product. The diagram shows the molecular arrangement of Icatibant along with a portion indicating an acetate group polymer (CH3COOH)n.*
FDA Label Image

Figure 2 (Ica00 0005 02)

Figure 2 (Ica00 0005 02)
A Kaplan-Meier survival plot comparing the proportion of patients not achieving a 50% reduction in symptoms over time (hours) after dose between two groups: FIRAZYR and placebo. The x-axis shows time from dose in hours, and the y-axis shows the proportion of patients. The FIRAZYR group shows a more rapid decrease compared to placebo.*
FDA Label Image

Fresenius Kabi Logo (Ica00 0005 03)

FDA Label Image

Figure A (Ica00 0005 04)

Figure A (Ica00 0005 04)
An instructional diagram showing the components of the Icatibant 10 mg/mL injection solution subcutaneous prefilled syringe. It labels the plunger, syringe barrel, and protective cap over the syringe tip, as well as the capped needle with needle cap seal, needle, and needle cap. It also depicts an alcohol wipe labeled as not included in the carton.*
FDA Label Image

Figure B (Ica00 0005 05)

Figure B (Ica00 0005 05)
Instructional illustration showing the steps to open the Icatibant 10 mg/mL injection, solution package. The series depicts removing or tearing open the outer packaging, then removing the individual injection vial or syringe container from the box, and finally the arrangement of the vial or syringe within the packaging interior.*
FDA Label Image

Figure C (Ica00 0005 06)

Figure C (Ica00 0005 06)
An instructional line drawing showing two hands preparing a subcutaneous injection. One hand holds a vial, while the other hand is removing a cap or preparing the syringe, demonstrating the process of medication preparation for injection.*
FDA Label Image

Figure D (Ica00 0005 07)

Figure D (Ica00 0005 07)
An instructional illustration showing a person holding a syringe and a needle cap, demonstrating the removal of the needle cap from the syringe. The hands are gloved, indicating aseptic technique.*
FDA Label Image

Figure E (Ica00 0005 08)

Figure E (Ica00 0005 08)
An instructional illustration showing two hands preparing a syringe by removing or twisting off the needle cap. The image focuses on the hand movements involved in readying a subcutaneous injection, consistent with administration instructions for Icatibant 10 mg/mL injection solution.*
FDA Label Image

Figure F (Ica00 0005 09)

Figure F (Ica00 0005 09)
An anatomical line drawing showing two marked square areas on the lower back, likely indicating injection sites for subcutaneous administration of the drug Icatibant 10 mg/mL.*
FDA Label Image

Figure G (Ica00 0005 10)

Figure G (Ica00 0005 10)
An instructional illustration depicting a hand applying or pressing a square patch or pad onto a person's lower side or abdomen area. The image likely demonstrates the site or method of application for a subcutaneous injection or treatment.*
FDA Label Image

Figure H (Ica00 0005 11)

Figure H (Ica00 0005 11)
An instructional illustration showing two hands preparing a syringe for injection, with one hand holding the syringe and the other removing a cap or cover from the needle.*
FDA Label Image

Figure I (Ica00 0005 12)

Figure I (Ica00 0005 12)
A black and white line drawing illustrating a hand holding a syringe with a needle, demonstrating the proper grip for subcutaneous injection of a solution. The hand grasp is shown clearly around the syringe barrel and plunger.*
FDA Label Image

Figure J (Ica00 0005 13)

Figure J (Ica00 0005 13)
An instructional line drawing illustrating a hand administering a subcutaneous injection into the lower abdominal area of a person. The image focuses on the proper site for injection, showing the hand holding a syringe near the abdomen.*
FDA Label Image

Figure K (Ica00 0005 14)

Figure K (Ica00 0005 14)
Instructional illustration showing injection angles for subcutaneous administration of Icatibant injection solution. One image shows a 45-degree angle and the other a 90-degree angle injection method into the skin, with hands holding a syringe positioned accordingly.*
FDA Label Image

Figure L (Ica00 0005 15)

Figure L (Ica00 0005 15)
Illustration showing a hand holding a syringe with a needle positioned near a lower abdomen, indicating the technique for subcutaneous injection of Icatibant injection solution.*
FDA Label Image

Figure M (Ica00 0005 16)

Figure M (Ica00 0005 16)
An instructional illustration depicting a hand holding a syringe with the needle inserted into the palm of another hand, indicating a subcutaneous injection technique with emphasis on injection site and needle placement.*
FDA Label Image

Figure N (Ica00 0005 17)

Figure N (Ica00 0005 17)
An instructional illustration showing a hand holding a syringe with an arrow indicating the direction of subcutaneous injection into the abdominal area. The image is likely intended to demonstrate proper administration technique for a subcutaneous injection.*
FDA Label Image

Figure O (Ica00 0005 18)

Figure O (Ica00 0005 18)
An instructional illustration showing a gloved hand disposing of a syringe into a sharps disposal container marked with a biohazard symbol. This image relates to safe injection disposal practices.*
FDA Label Image

Fresenius Kabi Logo (Ica00 0005 19)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Syringe Label)

Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Syringe Label)
Label for Icatibant Injection 30 mg per 3 mL (10 mg per mL) solution for subcutaneous use. The label includes the product name, strength, route, and manufacturer's information: Fresenius Kabi, made in Austria. It features two barcodes, one with the NDC 63323-574-86, and is marked Rx only.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Carton Panel Label)

Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Carton Panel Label)
Packaging label for Icatibant Injection 30 mg per 3 mL (10 mg per mL) by Fresenius Kabi USA, LLC. The label indicates a 3 mL single-dose prefilled syringe for subcutaneous use only, preservative free. It includes dosing and storage instructions, inactive ingredients, barcodes, and the manufacturer information from Lake Zurich, IL, made in Austria.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Syringe Label)

Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Syringe Label)
Label for Icatibant Injection, 30 mg per 3 mL (10 mg per mL) solution for subcutaneous use. The label shows the dosage strength, route of administration, and includes the NDC 63323-574-01. Manufactured by Fresenius Kabi, made in Austria, with lot and expiration date fields visible.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Carton Panel Label)

Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Carton Panel Label)
Packaging label for Icatibant Injection 10 mg/mL (30 mg per 3 mL), a subcutaneous injection solution. The label shows a single-dose 3 mL prefilled syringe. It is preservative free and labeled for Rx use only. The labeler is Fresenius Kabi USA, LLC, with manufacturing identified in Austria. The package includes barcodes and storage instructions.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Carton Panel Label)

Package Label (PRINCIPAL DISPLAY – Icatibant Injection 3 mL Carton Panel Label)
Packaging label for Icatibant Injection 30 mg per 3 mL (10 mg per mL) solution for subcutaneous use. The package contains 3 prefilled single-dose syringes of 3 mL each. The product is preservative-free and labeled for prescription use only by Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.